The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients
Clinical trial NCT00002373 · COMPLETED
Trial details
- NCT number
- NCT00002373
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.